D*action Sponsorships
April 27, 2016 Our recent paper, Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study, published April 6 in PLOS ONE,...
Know your D level
April 13, 2016 Last week, we presented the results of a study that we did with a combination of YOUR data and data from the randomized trial published in 2007 by Drs Lappe and...
Lower risk of cancer with vitamin D
April 6, 2016 Today, April 6, 2016, is the release of a truly definitive paper about vitamin D and cancer. In 2007, I read a paper by Lappe et al. and, cried. It was...
Here’s to the end of MS!
March 30, 2016 In December 2011, the National Multiple Sclerosis Society convened a two-day meeting of 40 MS experts from around the world. They were neurologists, epidemiologists, clinical trial specialists, laboratorians like me, molecular...
A Personal Study on Vitamin D and MS
March 23, 2016 Barbara van Amerongen and I met at a Vitamin D Workshop in Brugge, Belgium in 2012. She was very interested in what GrassrootsHealth was doing with a non-clinical trial research approach...
What Does the Equator have to do with MS?
March 16, 2016 The amount of material the major multiple sclerosis organizations have on vitamin D, latitude and MS is colossal. MS organizations are funding research, but it may not adequately represent vitamin D’s...
MS Treatment Protocol May Put Patients in Remission
March 2, 2016 Vitamin D is great for prevention of disease, but what about treatment after you’ve been diagnosed? We will study and report on leading-edge treatments using vitamin D as we find them....
The Importance of Regular Testing
February 24, 2016 The number one question I receive continues to be, “How much should I take?” The answer to that question also continues to be, “There is no magic amount. You have to...
Heart Health – Diabetes is a Major Risk Factor
February 17, 2016 As highlighted in our newsletter at the beginning of the month, February is American Heart Month. One of the major risk factors for cardiovascular disease is diabetes – a disease known...
HYLION: A New Translational Research Paradigm
February 10, 2016 We are proud to announce HYLIONTM: a set of tools developed with your help and input over the past several years designed to facilitate moving research into practice… NOW! It’s a...